DE2627772A1 - 1-substituierte azacycloalkan-2-one enthaltende traegermasse - Google Patents

1-substituierte azacycloalkan-2-one enthaltende traegermasse

Info

Publication number
DE2627772A1
DE2627772A1 DE19762627772 DE2627772A DE2627772A1 DE 2627772 A1 DE2627772 A1 DE 2627772A1 DE 19762627772 DE19762627772 DE 19762627772 DE 2627772 A DE2627772 A DE 2627772A DE 2627772 A1 DE2627772 A1 DE 2627772A1
Authority
DE
Germany
Prior art keywords
physiologically active
active substance
composition according
agent
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19762627772
Other languages
German (de)
English (en)
Other versions
DE2627772C2 (enExample
Inventor
Vithal Jagannath Rajadhyaksha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Whitby Research Inc
Original Assignee
Nelson Research and Development Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/588,247 external-priority patent/US3989816A/en
Priority claimed from US05/588,248 external-priority patent/US3989815A/en
Priority claimed from US05/588,235 external-priority patent/US3991203A/en
Application filed by Nelson Research and Development Co filed Critical Nelson Research and Development Co
Priority to DE2661009A priority Critical patent/DE2661009C2/de
Publication of DE2627772A1 publication Critical patent/DE2627772A1/de
Application granted granted Critical
Publication of DE2627772C2 publication Critical patent/DE2627772C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/41—Devices for promoting penis erection
    • A61F2005/415—Devices for promoting penis erection by inflatable means

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
DE19762627772 1975-06-19 1976-06-18 1-substituierte azacycloalkan-2-one enthaltende traegermasse Granted DE2627772A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE2661009A DE2661009C2 (de) 1975-06-19 1976-06-18 Verwendung eines 1-substituierten Azacycloalkan-2-ons als Penetrationsverstärker in einem eine physiologisch aktive Substanz enthaltenden physiologisch wirksamen Präparat

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58823475A 1975-06-19 1975-06-19
US05/588,247 US3989816A (en) 1975-06-19 1975-06-19 Vehicle composition containing 1-substituted azacycloheptan-2-ones
US05/588,248 US3989815A (en) 1975-06-19 1975-06-19 Novel N-bis-azacyclopentan-2-onyl alkanes
US05/588,235 US3991203A (en) 1975-06-19 1975-06-19 Vehicle composition containing 1-substituted azacyclopentan-2-ones

Publications (2)

Publication Number Publication Date
DE2627772A1 true DE2627772A1 (de) 1976-12-30
DE2627772C2 DE2627772C2 (enExample) 1991-04-25

Family

ID=27504982

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762627772 Granted DE2627772A1 (de) 1975-06-19 1976-06-18 1-substituierte azacycloalkan-2-one enthaltende traegermasse

Country Status (7)

Country Link
JP (1) JPS6037092B2 (enExample)
AU (1) AU504943B2 (enExample)
CA (1) CA1076028A (enExample)
DE (1) DE2627772A1 (enExample)
FR (1) FR2314731A1 (enExample)
GB (1) GB1553309A (enExample)
IE (1) IE43241B1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525199A (en) * 1981-05-04 1985-06-25 Nelson Research & Development Co. Method of improved pest control
US4405616A (en) * 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
JPS536327A (en) * 1976-07-08 1978-01-20 Mizusawa Industrial Chem Waterrresistant gypsum cureemolding structure
US4311481A (en) 1981-01-23 1982-01-19 Nelson Research & Development Company Method for improved dyeing
JPS5995212A (ja) * 1982-11-23 1984-06-01 Nitto Electric Ind Co Ltd 基剤組成物及び外用医薬組成物
LU84514A1 (fr) * 1982-12-09 1984-10-22 Oreal Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
JPH0627074B2 (ja) * 1984-07-25 1994-04-13 日東電工株式会社 医薬組成物
JPS61130207A (ja) * 1984-11-30 1986-06-18 Sunstar Inc 養毛剤
PT89837B (pt) * 1988-02-29 1994-01-31 Pfizer Processo para a preparacao de composicoes para aumentar o fluxo transdermico contendo uma 1-alquilazaciclo-heptan-2-ona ou uma cis-olefina
JPH0742213B2 (ja) * 1990-07-04 1995-05-10 花王株式会社 毛髪処理剤組成物
JPH0742214B2 (ja) * 1990-07-04 1995-05-10 花王株式会社 毛髪処理剤組成物
JPH0742215B2 (ja) * 1990-07-04 1995-05-10 花王株式会社 毛髪処理剤組成物
US6284754B1 (en) 1992-01-20 2001-09-04 Schwarz Pharma Ag Pharmaceutical compositions containing 1-oleylazacycloheptan-2-one as enhancing agent of transport across biological membranes
KR100212961B1 (ko) * 1992-12-31 1999-08-02 조민호 경피투여시스템
DE4341572C1 (de) * 1993-12-07 1995-06-22 Univ Dresden Tech Zahnriemengetriebe
DE19641437A1 (de) * 1996-10-08 1998-04-09 Basf Ag 1,3-Bis-(N-lactamyl)propane und deren pharmazeutische und kosmetische Verwendung
BRPI0511504A (pt) 2004-05-26 2008-01-22 Eisai R&D Man Co Ltd composto ou um sal farmaceuticamente aceitável do mesmo, e, agente preventivo ou terapêutico para uma doença resultante de beta-amilóides
ATE458729T1 (de) 2004-10-26 2010-03-15 Eisai R&D Man Co Ltd Amorphe form einer zimtsäureamidverbindung
JP4504210B2 (ja) * 2005-01-25 2010-07-14 花王株式会社 染毛剤組成物
AU2006316005A1 (en) * 2005-11-18 2007-05-24 Eisai R & D Management Co., Ltd. Process for production of cinnamamide derivative
TWI378091B (en) 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
US20080207900A1 (en) 2007-02-28 2008-08-28 Teiji Kimura Two cyclic oxomorphorin derivatives
US20100113348A1 (en) 2007-03-01 2010-05-06 Fumio Kamiyama Percutaneously absorbable preparation, process for production thereof and method for percutaneous absorption
US7935815B2 (en) 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
ES2529648T3 (es) 2007-08-31 2015-02-24 Eisai R&D Management Co., Ltd. Compuesto policíclico
JP2012020991A (ja) 2010-06-16 2012-02-02 Takasago Internatl Corp 経皮吸収促進剤、及びこれを含有する皮膚外用製剤
EP3395368A1 (en) 2014-10-30 2018-10-31 Asahi Kasei Kabushiki Kaisha Transdermal absorption enhancer and transdermal absorption enhancement aid

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE859016C (de) * 1944-07-06 1952-12-11 Basf Ag Verfahren zur Herstellung von N-substituierten Lactamen
US3268397A (en) * 1963-10-04 1966-08-23 Gen Aniline & Film Corp Method of controlling nematodes with nu-(branched-chained-alkyl) lactams
FR2001768A1 (fr) * 1968-02-12 1969-10-03 Gillette Co Compositions pour l'application topique de medicaments sur la peau
DE2338257A1 (de) * 1972-07-28 1974-02-14 Inventa Ag Verfahren zur herstellung n-substituierter lactame

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1053736B (de) * 1956-03-02 1959-03-26 Konink Nl Gist & Spiritusfabri Verfahren zur Erhoehung der Loeslichkeit therapeutisch wirksamer Stoffe in Wasser
DE1192208B (de) * 1960-05-13 1965-05-06 Basf Ag Verfahren zur Herstellung von Lactamen
CA1003847A (en) * 1971-10-29 1977-01-18 G A F Corporation Low molecular weight complexes of lactams and phenolic compounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE859016C (de) * 1944-07-06 1952-12-11 Basf Ag Verfahren zur Herstellung von N-substituierten Lactamen
US3268397A (en) * 1963-10-04 1966-08-23 Gen Aniline & Film Corp Method of controlling nematodes with nu-(branched-chained-alkyl) lactams
FR2001768A1 (fr) * 1968-02-12 1969-10-03 Gillette Co Compositions pour l'application topique de medicaments sur la peau
DE2338257A1 (de) * 1972-07-28 1974-02-14 Inventa Ag Verfahren zur herstellung n-substituierter lactame

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
C.R. Acad. Sc. Paris, Serie C, t.275, 1972, 581 *
Chem. Abstr. 74, 1971, 126718 m *
Chem. Abstr. 82, 1975, 140574 h *
Chem. Abstr. 85, 1976, 1086 z *
Chem. Ind., 1975, 177-178 *
HOUBEN-WEYL: Stickstoffverbindungen II u. III, 1958, S.570 *
J. Amer. Chem. Soc., 1948, 2117 *
J. Org. Chem. 18, 1087, 1953 *
Synthesis, 1971, 266-268 *
Tetrahedron Lett. 27, 1969, 2281-2284 *
Tetrahedron Lett. 9, 1966, 891-896 *

Also Published As

Publication number Publication date
FR2314731A1 (fr) 1977-01-14
JPS6037092B2 (ja) 1985-08-24
IE43241B1 (en) 1981-01-14
AU1506376A (en) 1977-12-22
CA1076028A (en) 1980-04-22
FR2314731B1 (enExample) 1978-11-03
AU504943B2 (en) 1979-11-01
JPS521035A (en) 1977-01-06
GB1553309A (en) 1979-09-26
DE2627772C2 (enExample) 1991-04-25
IE43241L (en) 1976-12-19

Similar Documents

Publication Publication Date Title
DE2627772C2 (enExample)
US4316893A (en) Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4444762A (en) Vehicle composition containing 1-substituted azacyclopentan-2-ones
DE3783683T2 (de) Hautpenetration verbessernde zusammensetzungen.
US4424210A (en) Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4423040A (en) Vehicle composition containing 1-substituted azacyclohexan-2-ones
US4415563A (en) Vehicle composition containing 1-substituted azacyclononan-2-ones
US3989816A (en) Vehicle composition containing 1-substituted azacycloheptan-2-ones
DE2615140C2 (de) Mittel mit einem pharmazeutischen Träger auf Basis von Pyrrolidonverbindungen und Verfahren zu dessen Herstellung
DE3788846T2 (de) 1-substituierte laktame enthaltende zusammensetzungen.
US4902676A (en) Compositions comprising N,N-dialkylalkanamides
JPS6127966A (ja) 浸透強化化合物
DE3875346T2 (de) Zusammensetzungen, die mit 1-oxo- oder thiokohlenwassserstoff substituierte azacycloalkane enthalten.
DE3415413C2 (enExample)
DE3141198A1 (de) 4,5-polymethylen-4-isothiazolin-3-one, verfahren zu deren herstellung und ihre verwendung als bakterizide und fungizide mittel
DE3788640T2 (de) Zubereitungen aus 1-acyl substituierte morpholines,-thiomorpholines und piperazinen.
DE2102172A1 (de) Neue Mitel zur Behandlung und Pflege der Haut
DE69434199T2 (de) Absorptionsförderer für topische pharmazeutische formulierungen
DE2241742A1 (de) Heilmittel zur aeusserlichen behandlung von bindegewebserkrankungen
US5256647A (en) Compositions comprising 1-substituted azacycloalkanes
US5108991A (en) Vehicle composition containing 1-substituted azacycloalkan-2-ones
DE3779833T2 (de) Zusammensetzungen enthaltend 1-substituierte azacycloalkane und deren verwendung.
DE2557431C2 (de) Topisch anwendbares antimikrobielles Präparat
US4992422A (en) Compositions comprising 1-substituted azacycloalkanes
US5218113A (en) N-substituted thiolactams

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 2661009

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 2661009

8125 Change of the main classification

Ipc: A61K 45/08

AH Division in

Ref country code: DE

Ref document number: 2661009

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WHITBY RESEARCH INC., RICHMOND, VA., US

AH Division in

Ref country code: DE

Ref document number: 2661009

Format of ref document f/p: P